Methylprednisolone pulse therapy as an adjuvant treatment of Streptococcus pneumoniae meningitis complicated by cerebral infarction-a case report and review of the literature

Childs Nerv Syst. 2020 Feb;36(2):229-233. doi: 10.1007/s00381-019-04485-6. Epub 2020 Jan 2.

Abstract

Purpose: The role of methylprednisolone pulse therapy as adjuvant treatment of Streptococcus pneumoniae meningitis complicated by cerebral infarction has rarely been reported.

Methods: We reported a case report and also performed a systematic literature review.

Results: A 1-year 2-month-old boy who presented with high fever, status epilepticus, and septic shock was diagnosed with cerebral infarction caused by Streptococcus pneumoniae meningitis on magnetic resonance imaging (MRI). He was treated with methylprednisolone pulse therapy and his clinical condition gradually improved thereafter. At the follow-up visit 1 year after discharge, he was able to sit without support, but he had moderate delays in speech and developmental milestones and epilepsy sequelae.

Conclusion: In severe cases, the use of high-dose methylprednisolone should be considered to modulate the inflammatory response in patients with severe cerebral infarction caused by Streptococcus pneumoniae meningitis.

Keywords: Cerebral infarction; Meningitis; Methylprednisolone; Streptococcus pneumoniae.

Publication types

  • Case Reports
  • Systematic Review

MeSH terms

  • Cerebral Infarction* / complications
  • Cerebral Infarction* / diagnostic imaging
  • Cerebral Infarction* / drug therapy
  • Child, Preschool
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Meningitis, Pneumococcal* / complications
  • Meningitis, Pneumococcal* / drug therapy
  • Methylprednisolone* / therapeutic use

Substances

  • Methylprednisolone